血清蛋白与纳米粒子的结合关系
Benjamin P Stordy1,2, Zahra Sepahi1,2, Gabriel D Patrón3,4
1Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3E3, Canada.
Journal of the American Chemical Society
|June 9, 2025
概括
针对性的纳米颗粒面临血清蛋白结合的挑战. 一个新的结合比度指标预测了血清中的纳米粒子细胞结合效率,改善了向传递.
科学领域:
- 生物医学工程
- 纳米技术
- 提供药物
背景情况:
- 有针对性的纳米颗粒被设计为向特定的细胞输送医疗剂.
- 血清蛋白对纳米颗粒的吸附可以阻碍它们与细胞的结合.
- 了解血清蛋白与细胞受体之间的相互作用对于纳米粒子的有效性至关重要.
研究的目的:
- 研究血清蛋白与纳米颗粒上的目标受体之间的竞争性结合动态.
- 在生物流体中开发纳米粒子准效率的预测度量.
- 提高纳米颗粒的设计以改善细胞受体结合.
主要方法:
- 在251个不同的纳米粒子设计中测试了血清蛋白结合亲和力.
- 量化了血清蛋白和细胞受体与纳米粒子表面的竞争性结合.
- 开发并验证了一种定量指标,即结合比,用于预测纳米粒子-细胞相互作用.
主要成果:
- 发现血清蛋白和受体与纳米颗粒的结合关系是细胞结合的关键决定因素.
- 开发的结合率指标在识别有效的纳米粒子设计时显示了90%的灵敏度和88%的特异性.
- 使用结合比指导纳米粒子设计,从而提高了针对细胞受体的结合效率.
结论:
- 结合率是一种经过验证的定量指标,用于在血清中设计具有更好的准能力的纳米粒子.
- 这一指标促进了纳米颗粒的合理设计,克服了血清蛋白干扰,以有效地传递细胞.
- 这些发现为优化基于纳米粒子的疗法提供了一条途径, 以提高临床结果.
相关概念视频
Factors Affecting Protein-Drug Binding: Drug-Related Factors
217
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
217
Drug Distribution: Plasma Protein Binding
6.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.8K
Drug Binding to Blood Components
272
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
272
Factors Affecting Protein-Drug Binding: Protein-Related Factors
280
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
280
Affinity and Avidity
36.7K
Overview
36.7K
Factors Affecting Protein-Drug Binding: Drug Interactions
292
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
292


